5α-reductase Inhibitors and Risk of High-grade or Lethal Prostate Cancer

IMPORTANCE: 5α-reductase inhibitors (5ARIs) are widely used for benign prostatic hyperplasia despite controversy regarding potential risk of high-grade prostate cancer with use. Furthermore, the effect of 5ARIs on progression and prostate cancer death remains unclear. OBJECTIVE: To determine the ass...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Preston, Mark A., Wilson, Kathryn, Markt, Sarah C., Ge, Rongbin, Morash, Christopher, Stampfer, Meir J., Loda, Massimo F., Giovannucci, Edward, Mucci, Lorelei A., Olumi, Aria F.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4122627/
https://ncbi.nlm.nih.gov/pubmed/24887392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2014.1600
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares